Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Support For Cosmetic Allergen Labeling Has Foundation In Consumers' ‘Right To Know’

Oct 28 2021

• By Lauren Nardella

• Source: Alamy

Related Content

US FDA’s Stance On CBD In Cosmetics Hasn’t Changed, And Neither Have Marketing Challenges

Oct 05 2020

US FDA’s Cosmetics Director Katz Cites Fragrance Allergens, Talc-Containing Products Among Priorities

Oct 07 2020

FDA Moves Forward With Planned Cosmetic Allergy Survey, Defends Practical Utility, Statistical Power

Nov 20 2019

50 Years Later, FDA And Cosmetics Industry At Odds Again Over Asbestos

Feb 14 2020

US Cosmetics Modernization Bill Relaunched, Now With Fragrance Allergen Labeling, PFAS Ban

Jun 21 2021

US FDA Inaction On Formaldehyde In Hair-Smoothing Products ‘Unconscionable,’ Petitioners Say

Jun 16 2021

California On Verge On Legalizing CBD-Containing Cosmetics Along With Dietary Supplements, Foods

Oct 01 2021

50 For 50: All Talc-Containing Cosmetic Samples Found Asbestos-Free In Latest US FDA Tests

Oct 26 2021

Additional Topics

International United States FDA Cosmetics Regulation Business Strategies Commercial Compliance Consumer Cosmetic Ingredients Ingredients Manufacturing Policy Safety Legislation

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window